Biden's COVID-19 relief bill will head to the Senate after House vote

The House passed President Biden's $1.9 trillion COVID-19 relief package in a 219-212 vote nearly along party lines early Saturday. Two Democrats, Reps. Jared Golden (D-Maine) and Kurt Schrader (D-Ore.) voted against the bill with Republicans, who consider the package too expensive, taking particular opposition to measures like funding for state and local governments.
The legislation, which includes $1,400 direct payments for individuals earning up to $75,000 per year (as well as couples earning a combined $150,000) and extends enhanced unemployment benefits through August, will now head to the Senate, where its contents could change, The New York Times reports.
The bill includes a proposal that would raise the federal minimum wage to $15 per hour by 2025, but Democrats, who narrowly hold the Senate, are using reconciliation, a process that will allow them to pass the bill with a simple majority and avoid Republican obstruction. Reconciliation comes with strict limits on what can be included in a measure, and the Senate's nonpartisan parliamentarian ruled against the wage hike.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Several congressional progressives, who are prioritizing the increase, criticized the decision and called for Senate Democrats to move forward anyway, but the White House said Biden, while disappointed, respects the ruling. Meanwhile, Senate Majority Leader Chuck Schumer (D-N.Y.) and his colleagues are exploring alternatives, including an escalating tax on the payrolls of large corporations whose employees earn less than a certain hourly wage. It's unclear if that will qualify under the rules of reconciliation. Read more at The Associated Press and The New York Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published